|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 20021 | Gem-(R)CHOP versus (R)CHOP : a randomized Phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's Lymphoma |
| 20011 | A randomized trial of BEAM + PBSCT versus single agent high-dose therapy followed by BEAM + PBSCT in patients with relapsed Hodgkin's disease (HD-R2 protocol). |
| 20982 | Prospective controlled trial in clinical stages I-II supradiaphragmatic Hodgkin'Disease. Evaluation of treatment efficacy, (long term) toxicity and Quality of Life in two different prognostic subgroups. |
| 20931 | Protocol H8 for a prospective controlled trial in stage I-II supradiaphragmatic Hodgkin's disease. Evaluation of treatment efficacy and (long term) toxicity in three different prognostic subgroups. H8 Trial |
| 20884 | Prospective randomized controlled trial of adjuvant involved field radiotherapy after MOPP/ABV hybrid chemotherapy in advanced Hodgkin disease. H34 Trial |
| 20881 | Phase III study on Hodgkin's disease supradiaphragmatic clinical stages I and II |
| 20811 | Phase II study on morbus Hodgkin clinical stages IIIB and IV |
| 20051 | The H10 EORTC/GELA/IIL randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. |
| 20991 | Diffuse large B cell and peripheral T cell non-Hodgkin's lymphomas in the elderly. Influence of prolonged oral etoposide added to CHOP combination chemotherapy in patients with good physiological status. An EORTC phase II-III trial including geriatric assessment and quality of life. |
| 20013 | Chlorambucil versus 2 X 2 Gy involved field radiotherapy in stage III/IV previously untreated follicular lymphoma patients. |
| 20012 | BEACOPP (4 cycles escalated + 4 cycles baseline) versus ABVD (8 cycles) in stage III & IV Hodgkin's Lymphoma |
| 20992 | Diffuse large B cell and peripheral T cell NHL in the frail elderly. Progressive and cautious treatment strategy in poor status patients. A phase II trial with emphasis on geriatric assessment and quality of life. Version 2.0 (13 December 2001) |
| 20995 | Treatment of mantle cell lymphomas at advanced stages: prospective randomized comparison of myeloabative radiochemotherapy followed by blood stem cell transplantation versus maintenance with interferon alpha in first remission after initial cytoreductive chemotherapy with an anthracycline containing combination. A European Intergroup Trial. |
| 20971 | A Phase III randomized study on low-dose total body irradiation and involved field radiotherapy in patients with localized, stages I and II, low grade non-Hodgkin's lymphoma |
| 20981 | Intergroup Collaborative Study (EORTC 20981) "Rituximab (Mabthera*) in remission induction and maintenance treatment of relapsed / resistant follicular non-Hodgkin's lymphoma : a phase III randomized clinical trial" lymphoma : a phase III randomised clinical trial - Intergroup Collaborative Study (EORTC 20981) Including Amenmdment 4 (28.6.2000) |
| 20961 | A phase II clinical trial of anti-helicobacter pylori treatment in endoscopically diagnosed low-grade localized gastric lymphoma |
| 20962 | Evaluating the MBVP chemotherapy schedule followed by consolidating radiotherapy in non AIDS related primary CNS lymphoma (NAPCL) |
| 20963 | Marrow ablative chemo-radiotherapy and autologous stem cell transplantation followed by interferon - alpha maintenance treatment versus interferon-alpha maintenance alone after a chemotherapy induced remission in patients with stages III or IV follicular HNL. A prospective, randomised phase III clinical trial. |
| 20932 | Randomized investigation of the value of radiotherapy in complete remission after chemotherapy for patients with stage II, III or IV non Hodgkin's lymphoma of intermediate or high grade histology |
| 20921 | Fludarabine versus conventional combination chemotherapy (CVP) in patients with stages III and IV low grade malignant non-Hodgkin's lymphoma. A prospective randomized controlled phase III trial |
| 20901 | A prospective randomized controlled phase III trial on consolidation therapy with autologous bone marrow rescue after standard chemotherapy for intermediate grade and high grade non-Hodgkin's lymphoma |
| 20872 | Phase III trial for the treatment of elderly patients (> 70 years) with stages II, III and IV non-Hodgkin's lymphomas of intermediate and high grade malignancy comparing CHOP vs a new combination of VP16, mitoxantrone and prednimustine |
| 20882 | Phase II Chemotherapy with Carbetimer in Patients with Stage III/IV Low-Grade non-Hodgkin's Lymphoma Who Have Relapsed After First-Line Treatment (Summary Last Modified 07/88) |
| 20871A | Phase III for the treatment of localized intermediate and high grade gastrointestinal tract non-Hodgkin's lymphoma - stage I - |
| 20871B | Phase III for the treatment of localized intermediate and high grade gastrointestinal tract non-Hodgkin's lymphoma - stage II - |
| 20861 | Phase II Chemotherapy with 5-AZA-2'-Deoxycytidine in Patients with Relapsed or Refractory Stage III/IV Hodgkin's Disease |
| 20856 | Maintenance of remission with recombinant alpha-2 Interferon (Roferon-A) in patients with stages III and IV low grade Non-Hodgkin's lymphoma |
| 20855 | Phase III trial comparing CHVmP/VCR-BLM vs modified ProMACE/MOPP regimen for patients with stages II, III, IV lymphomas of intermediate and high grade malignancy |
| 20852 | Phase II Salvage Chemotherapy with M-CAVe (CTX/ADR/VBL/MTX) Alternating with CEC (CCNU/VP-16/CLB) in MOPP-Refractory Hodgkin's Disease |
| 20851 | Phase II Chemotherapy Using ARA-C in Patients with Hodgkin's Disease Who Have Failed MOPP and ABVD Combination Chemotherapy |